Market Overview

UPDATE: Citigroup Downgrades Bankrate to Neutral on Lead Generation Challenges

Share:

Citigroup downgraded Bankrate (NYSE: RATE) from Buy to Neutral and lowered the price target from $14.00 to $12.00.

Citigroup commented, "Insurance & Credit Card Verticals are driving the weakness at RATE as the process of signing up new carriers/agents under the higher quality and more monetizeable leads is taking much longer than expected. Furthermore, RATE noted that its Credit Cards business remains under significant pressure as issuers have been cautious with credit card approvals. … Rev & EBITDA declined Y/Y in Q4, and EBITDA margins compressed materially. Pressure will continue on the biz throughout 1H:13 as Insurance CPL and Credit CPA continue to face challenges. Until we see improvement in these segments, we're stepping to the side."

Bankrate closed at $9.86 on Tuesday.

Latest Ratings for RATE

DateFirmActionFromTo
Feb 2017Initiates Coverage OnOutperform
Nov 2016UpgradesHoldBuy
Aug 2016Initiates Coverage onHold

View More Analyst Ratings for RATE
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Downgrades Analyst Ratings

 

Related Articles (RATE)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
INFOCantor FitzgeraldMaintains65.0
LBRDADeutsche BankMaintains140.0
IIVIDeutsche BankMaintains40.0
LINWells FargoMaintains228.0
INFOWells FargoMaintains80.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

UPDATE: Wedbush Upgrades Ironwood Pharmaceuticals to Neutral on LINZESS Strength

UPDATE: Citigroup Downgrades Sapient Corporation to Neutral on Soft 2013 Outlook